Industry Focus
Healthcare: Earnings Round-up -- Celgene and Gilead Sciences
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:28:55
- Mas informaciones
Informações:
Sinopsis
How Celgene and Gilead Sciences results are fueling their stock prices this quarter, plus Merck’s Keytruda closes the sales gap between it and Bristol-Myers Squibb’s Opdivo.
